Systolic Blood Pressure and Risk of Valvular Heart Disease: A Mendelian Randomization Study
Systolic Blood Pressure and Risk of Valvular Heart Disease: A Mendelian Randomization Study
复制标题
DOI:
10.1001/jamacardio.2019.2202
复制
发表时间:
2019-08-01
期刊:
影响因子:
24
通讯作者:
Rahimi, Kazem
中科院分区:
文献类型:
--
作者:
Nazarzadeh, Milad;Pinho-Gomes, Ana-Catarina;Rahimi, Kazem
Key PointsQuestionIs elevated systolic blood pressure a risk factor for major valvular heart disease? FindingsIn this mendelian randomization study of 329237 individuals, genetically associated 20-mm Hg increments of elevated systolic blood pressure appeared to be associated with a higher risk of aortic stenosis, aortic regurgitation, and mitral regurgitation. MeaningLifetime exposure to elevated systolic blood pressure may be associated with an increased risk of major valvular heart disease, suggesting that blood pressure lowering might be a useful strategy for prevention of this condition.ImportanceModifiable risk factors for valvular heart disease remain largely unknown, which limits prevention and treatment. ObjectiveTo assess the association between systolic blood pressure (BP) and major valvular heart disease. Design, Setting, and ParticipantsA UK Biobank population-based cohort of 502602 men and women aged 40 to 96 years at baseline was evaluated through mendelian randomization using individual participant data. Inclusion criteria were valid genetic data and BP measurements. The participants were recruited between 2006 and 2010; data analysis was performed from June 2018 to January 2019. ExposuresSystolic BP was measured during clinical assessment and instruments for the genetic effect of high BP were identified from variants that were independently (linkage disequilibrium threshold of r(2)